Author： Eaton J.W. Hunt N.H.
Publisher： Maney Publishing
ISSN： 1743-2928
Source： Redox Report, Vol.5, Iss.6, 2000-12, pp. : 313-313
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Leflunomide: benefits in RA still apparent at 2 years
Inpharma, Vol. 1, Iss. 1266, 2000-01 ,pp. :
Access to resources
Recommend
Not such a bad treatment after all
By CARNWATH TOM
Journal of Substance Use, Vol. 8, Iss. 1, 2003-04 ,pp. :
Is there still a place for high-dose methotrexate in paediatric ALL?
Inpharma, Vol. 1, Iss. 1498, 2005-01 ,pp. :
Atherosclerosis is an Inflammatory Disorder After All
Current Topics in Medicinal Chemistry, Vol. 6, Iss. 2, 2006-01 ,pp. :